The gene for Nijmegen breakage syndrome (V2) is not located on chromosome 11.
The gene for Nijmegen breakage syndrome (V2) is not located on chromosome 11.
复制标题
奈梅亨断裂综合征 (V2) 的基因并不位于 11 号染色体上。
DOI:
--
复制
发表时间:
1996
影响因子:
9.8
通讯作者:
M. Oshimura
中科院分区:
文献类型:
--
作者:
K. Komatsu;S. Matsuura;H. Tauchi;S. Endo;S. Kodama;D. Smeets;C. Weemaes;M. Oshimura
Ataxia telanglectasia (AT) is an autosomal recessive disorder characterized by oculocutaneous telangiectasia and cerebellar ataxia. Individuals with this disorder display immunological impairments, hypersensitivity to ionizing radiation, and a predisposition to cancer. There has been reported genetic heterogeneity in AT, which appeared to include four genetic complementation groups in classical AT - i.e., A, B/C, D, E - and two variants, so-called Nijmegen breakage syndrome (NBS), V1 and V2. Among the four groups of classical AT, no significant differences in clinical appearance have been seen. Familial linkage analyses have produced evidence that genes for all four complementation groups in classical AT reside in a narrow region on chromosome 11q22-23. On the other hand, NBS patients have neither cerebellar ataxia nor telanglectasia but do display microcephaly and a developmental delay. However, patients share features with AT, such as high radiosensitivity, radioresistant DNA synthesis (RDS), and chromosome instability, suggesting that the same pathway (or part thereof) is impaired in both syndromes. The underlying gene for NBS has not yet been identified, and its location in the human genome is still unknown. 15 refs., 3 figs.